JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, H. J.
Right arrow Articles by Belvisi, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, H. J.
Right arrow Articles by Belvisi, M. G.

Vol. 286, Issue 2, 952-958, August 1998

Inhibition of Cholinergic Neurotransmission in Guinea Pig Trachea by NS1619, a Putative Activator of Large-Conductance, Calcium-Activated Potassium Channels

Hema J. Patel, Mark A. Giembycz, Joelle E. Keeling, Peter J. Barnes and Maria G. Belvisi3

Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London, England

Indirect functional studies suggest that large-conductance calcium-activated potassium channels (BKCa channels) are involved in the control of ACh release from postganglionic, parasympathetic nerve terminals in the airways. The role of BKCa channels in regulating cholinergic neurotransmission was assessed by 1) investigating the effect of the putative BKCa channel opener NS1619 on cholinergic contractile responses and ACh output evoked by electrical field stimulation (EFS: 40 V, 0.5 ms, 4 Hz for 15 s every 4 min) and comparing the effect obtained with the inhibition of EFS-evoked ACh release by oxotremorine M, a muscarinic agonist, and 2) evaluating the sensitivity of these responses to the BKCa channel blocker iberiotoxin (IbTX). NS1619 (30 µM) inhibited cholinergic contractile responses by 60.0%. In contrast, NS1619 had no effect on contractile responses evoked by exogenous ACh (1 µM), which indicated that it was acting prejunctionally. NS1619 (30 µM) significantly inhibited EFS-induced ACh release by 33.9%. Oxotremorine M suppressed EFS-evoked ACh release in a concentration-dependent manner (at 1 µM, 77.4% inhibition). In neither case was the inhibition reversed by IbTX (100 nM). Collectively, the mechanical data suggest that NS1619 inhibits cholinergic contractile responses by interacting prejunctionally. The failure of IbTX to reverse the inhibitory action of NS1619 and oxotremorine M on ACh release indicates that activation of muscarinic autoinhibitory receptors is not coupled to the opening of IbTX-sensitive BKCa channels. Therefore, we propose that caution be exercised when using NS1619 as an activator of BKCa channels.


0022-3565/98/2862-0952$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.